NCT00617708 2022-02-08S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryNational Cancer Institute (NCI)Phase 1/2 Completed134 enrolled 12 charts